Exhibit 99.1

   PHC, INC. ANNOUNCES FINANCIAL RESULTS FOR THE SECOND QUARTER OF FISCAL 2007

   Patient Care Revenue Increases 22.9%, Driving 14.4% Increase in Net Revenue
 Company Maintains Profitability Despite Start-Up Expenses For Las Vegas Market
                                    Expansion


FOR IMMEDIATE RELEASE

Company Contact:           Investor Relations Contact:
_________________          ____________________________

PHC, Inc.                  Hayden Communications, Inc.
Bruce A. Shear             Matt Hayden or Peter Seltzberg
978-536-2777               843-272-4653

FINANCIAL HIGHLIGHTS:

>    Net  revenue up 14.4% to  second-quarter  record  $10.0  million  vs.  $8.7
     million in the same period last year

>    22.9%  increase in patient care revenue and 12.2%  increase in patient days
     over the same period last year

>    Significant investment through January 2007 in Las Vegas market,  including
     start-up costs in anticipation of our 10-year,  $80 million  agreement with
     Health Plan of Nevada's Behavioral Healthcare Options network agreement

>    Record $7.9 million quarterly revenues in Patient Care segment

>    Cash  position  increases to $4.1 million  primarily due to $2.0 million in
     new equity

>    Stockholders'  equity increases 21.7% to $16.4 million compared to June 30,
     2006


Peabody, Mass., February 13, 2007 -- PHC, Inc., d.b.a. Pioneer Behavioral Health
(OTC Bulletin  Board:  PIHC),  a leading  provider of inpatient  and  outpatient
behavioral  health  services,  today  announced  its fiscal 2007 second  quarter
financial results, for the period ended December 31, 2006.

                                       4

                            Key Financial Indicators
              (all numbers in thousands, except per-share amounts)
                           Q2 2007       Q2 2006      Increase     % Change
                                                                  (decrease)
Consolidated revenues       $9,952       $8,702       $1,250        14.4%
Patient care revenues       $7,947       $6,465       $1,481        22.9%
Pharmaceutical study
 revenues                   $  874       $1,084       $ (210)      (19.4%)
Contract support service
 revenues                   $1,132       $1,153       $  (21)       (1.8)%
Income from operations      $  605       $  549       $   56        10.2%
Pretax Income               $  423       $  411       $   12         2.9%
Net Income                  $  261       $  347       $  (86)      (24.8%)
Earnings per share -        $ 0.01       $ 0.02       $(0.01)      (50.0%)
 Basic Diluted              $ 0.01       $ 0.02       $(0.01)      (50.0%)

Financial Results

Total net revenue from  operations  increased  14.4 percent to $10.0 million for
the three months ended  December 31, 2006 from $8.7 million for the three months
ended December 31, 2005. Net patient care revenue increased 22.9 percent to $7.9
million for the quarter from $6.5  million for the same quarter last year.  This
increase  in revenue is due  primarily  to the  addition  of the 20  adjudicated
juvenile  beds at Detroit  Behavioral  Institute,  which  contributed  to a 12.2
percent  increase  in patient  days for the three  months  compared  to the same
period last year. Revenue from pharmaceutical  studies decreased 19.4 percent to
$874,000  for the quarter  compared to $1.1  million for the three  months ended
December  31, 2005 due to the  cyclical  nature of the  pharmaceutical  research
business,  where the size and number of clinical  trial  starts and stops change
daily.  Contract support  services  revenue provided by Wellplace  decreased 1.8
percent to $1.1  million for the quarter  from $1.2 million for the same quarter
last year.

"The  investments  and  developments  we have made in our Patient  Care  segment
during  fiscal  2006 have begun to yield the  significant  contributions  to our
revenues that we  anticipated,"  commented  Bruce A. Shear,  President and Chief
Executive Officer of Pioneer  Behavioral  Health.  "The 22.9 percent increase in
patient care revenue  resulted from the addition of the 20 adjudicated  juvenile
beds at Detroit Behavioral  Institute,  which enabled a 12.2 percent increase in
patient days for the quarter. This also represented an acceleration of 560 basis
points in patient care revenue  growth  compared to the first fiscal  quarter of
2007. We continue to view bed count as a key metric of our financial health, and
even as we  currently  have the highest bed count totals and patient days levels
in our Company's history, we stand poised to further accelerate this growth next
year following the planned expansion in Las Vegas."

Total operating  expenses for the quarter increased 15.0 percent to $9.3 million
from $8.2  million  during the second  quarter  of last year.  Included  in this
increase was a 28.9 percent  increase in patient care expenses,  through January
2007, the Company has invested  approximately  $500,000 in the Las Vegas market,
including  $400,000 in the Seven Hills  project and  $100,000 in the start-up of
our  10-year,  $80 million  agreement  with  Health Plan of Nevada's  Behavioral
Healthcare  Options network  agreement.  The increase in operating expenses also
included a $100,100, or 17.1 percent,  increase in other expenses and 13% higher
administrative  costs to  $369,000,  compared to last year's  period,  which was
primarily due to various set-up and other  infrastructure  costs necessitated by
the expansion at Detroit Behavioral Institute and our new software installation.

Income from  operations  for the quarter was $605,000,  up 10.2 percent from the
$549,000  reported for the same period last year.  Interest  expense of $212,000
was 21 percent higher, due in large part to an earn-out related $80,000 increase
in interest expense at Pivotal Research Centers. Net income for the three months
was  $261,000,  or $0.01 per fully  diluted  share (based on 19.4 million  fully
diluted shares)  compared to net income of $347,000,  or $0.02 per fully diluted
share (based on 19.3 million shares) for the second quarter last year.

                                       5

This year's second fiscal  quarter was the second  consecutive  quarter in which
the Company  recorded an income tax  provision  assuming an estimated 39 percent
corporate tax rate, while in the prior-year  quarter,  the Company recorded a 16
percent tax rate for the income tax provision. Had the Company incurred the same
39 percent tax rate in the year-ago period, net income for the second quarter of
fiscal 2006 would have been  $255,000,  which is  marginally  lower than in this
year's second quarter.

The  Company's  provision  for  doubtful  accounts in the quarter  decreased  to
$347,000 from $476,000 in the year-ago same period.  The  percentage of bad debt
expense to net patient care revenue for the quarter ended  December 31, 2006 was
4.4 percent compared to 7.4 percent last year.

For the  six-month  period  ended  December  31,  2006,  total net revenue  from
operations increased 13.4 percent to $20.0 million compared to $17.6 million for
the first six months last year. Net patient care revenue  increased 20.1 percent
to $15.8  million for the six months from $13.2 million for the same period last
year. Revenue from pharmaceutical studies decreased 19.5 percent to $1.9 million
for the  six-month  period  from $2.4  million  for the same  period  last year.
Contract support services revenue provided by Wellplace increased 9.0 percent to
$2.3  million  for the six months  from $2.1  million  for the six months  ended
December 31, 2005.

Patient  care  expenses in  treatment  centers  increased  25.1  percent to $8.2
million for the six months from $6.6  million last year.  Patient care  expenses
related  to  pharmaceutical  or  research  division  decreased  15.4  percent to
$908,000  for the six  months  from $1.1  million  last year.  Contract  support
services expenses increased 28.8 percent to $1.5 million for the six months from
$1.2 million last year.  Administrative  expenses increased 15.5 percent to $6.2
million for the six months from $5.4 million for the six months  ended  December
31, 2005.

Income from  operations was $1.2 million for the first six months of both fiscal
2007 and 2006.  Net income was  $544,000,  or $0.03 per basic and fully  diluted
share  (based  on 19.3  million  shares),  down  25.5  percent  compared  to the
$731,000,  or $0.04 per basic and fully  diluted  share  (based on 19.3  million
shares) last year.  Our blended  average tax rate for the six-month  period this
year was 39% as  compared  to 18% in last year's  same  period.  Adjusting  last
year's  six-month  result for this year's  comparable  tax rate,  our net income
would have been $544,000, largely unchanged compared to this year's same period.

Mr. Shear continued,  "Our presence in the Las Vegas metropolitan area, which we
expect to be a key driver of our future growth, continues to expand. The opening
of the Seven Hills  Behavioral  Institute will be complemented by the strong and
growing presence of our Harmony Healthcare subsidiary,  which serves 21 separate
properties  in that area.  We are excited to announce that we have begun work on
the 10-year,  $80 million  contract with Health Plan of Nevada,  as announced in
December, under which Harmony will continue to provide inpatient hospitalization
services,   outpatient  services,   individual  and  group  therapy,  medication
management,  psychological  testing,  as well as crisis and triage  care for all
Health  Plan of Nevada and  Behavioral  Healthcare  Options  members in Southern
Nevada and Northwestern Arizona."

The Company  reported $4.1 million in cash as of December 31, 2006,  compared to
$1.8  million in June 30, 2006.  The increase in the cash account was  primarily
due to $2.0 million in new equity financing that the company received at the end
of the quarter. Consequently, the Company's balance sheet had a current ratio of
2:3 on December  31, 2006 and  stockholders'  equity  increased  21.7 percent to
$16.4 million as of December 31, 2006 from $13.5 million as of June 30, 2006.

Mr.  Shear  concluded,  "We are pleased  with the  quarterly  results,  and look
forward  to a  strong  second  half  of  the  year.  Despite  certain  necessary
incremental  expenses  associated  with the $80 million  contract we closed with
Behavioral  Healthcare  Options,  we had  healthy  operating  cash  flow of $1.3
million, pre-tax income of $423,000, which is close to its historical high point
in this seasonably  slower quarter for us, and maintained  profitability for the
24th consecutive  quarter. Our balance sheet continues to strengthen as well, as
evidenced  by our higher cash  position  and  ability to pay down our  revolving
credit  line and term loan  debt,  which we reduced by  $497,000  and  $500,000,
respectively.  We have cause for optimism as we progress  towards our  long-term
strategic goals."

                                       6

Teleconference Information

The  Company  will host a  conference  call to discuss  the fiscal  2007  second
quarter  results  on  Wednesday,  February  14,  2007  at 9 a.m.  Eastern  Time.
Interested  parties  within  the  United  States  can access the call by dialing
866-277-1184  and  international  callers  may  dial  617-597-5360.  Please  use
passcode  47122216.  A replay of the call also will be available  until February
21, 2007 at 888-286-8010 for callers within the United States,  and 617-801-6888
for international  callers.  Please use passcode  58872090 for the replay.  This
call is being  webcast by CCBN,  and can be accessed at PHC,  Inc.'s web site at
www.phc-inc.com.  The webcast is also being  distributed  over  CCBN's  Investor
Distribution Network to both institutional and individual investors.  Individual
investors can listen to the call through CCBN's  individual  investor  center at
www.fulldisclosure.com,  or by  visiting  any of the  investor  sites in  CCBN's
Individual  Investor  Network.  Institutional  investors can access the call via
CCBN's    password-protected   event   management   site,    StreetEvents,    at
www.streetevents.com.

                                       7

About Pioneer Behavioral Health

Pioneer   Behavioral  Health  operates  companies  that  provide  inpatient  and
outpatient behavioral health care services,  clinical research and Internet- and
telephonic-based   referral  services.  The  companies  contract  with  national
insurance  companies,  government  payors,  and major  transportation and gaming
companies, among others, to provide such services. For more information,  please
visit www.phc-inc.com or www.haydenir.com.

Statement under the Private Securities Litigation Reform Act of 1995:

Statement under the Private Securities Litigation Reform Act of 1995: This press
release may include  "forward-looking  statements" that are subject to risks and
uncertainties.  Forward-looking statements include information about possible or
assumed future  results of the operations or the  performance of the company and
its future plans and objectives.  Various future events or factors may cause the
actual results to vary materially  from those  expressed in any  forward-looking
statements  made in this press  release.  For a discussion  of these factors and
risks,  see the company's annual report on Form 10-K for the most recently ended
fiscal year.


                               - tables follow -

                                       8





                           PHC, INC. AND SUBSIDIARIES
                      CONDENSED CONSOLIDATED BALANCE SHEETS
                                               December 31,        June 30,
                           ASSETS                 2006               2006
                                              ___________      ___________
                                               (unaudited)
Current assets:
   Cash and cash equivalents                  $ 4,150,210      $ 1,820,105
   Accounts receivable, net of allowance
    for doubtful accounts of $3,389,836
    at December 31, 2006 and $3,100,586
    at June 30, 2006                            6,736,235        6,955,475
   Pharmaceutical receivables                   1,466,484        1,470,019
   Prepaid expenses                               863,292          490,655
   Other receivables and advances                 853,165          751,791
   Deferred income tax asset                    2,918,779        3,110,000
                                              ___________      ___________
       Total current assets                    16,988,165       14,598,045
   Accounts receivable, non-current                35,000           40,000
   Other receivable                                47,680           53,457
   Property and equipment, net                  2,018,990        1,799,888
   Deferred financing costs, net of
    amortization of $124,899 at December
    31, 2006 and $106,422 June 30, 2006            98,546          117,023
   Customer relationships, net of amortization
    of $320,000 at December 31, 2006
     and $260,000 at June 30, 2006              2,080,000        2,140,000
   Goodwill                                     3,164,643        2,664,643
   Other assets                                   828,190          571,931
                                              ___________      ___________
       Total assets                           $25,261,214      $21,984,987
                                              ===========      ===========

LILIABILITIES AND STOCKHOLDERS' EQUITY
Current liabilities:
   Accounts payable and short-term notes
    payable                                   $ 1,903,578     $  1,518,615
   Current maturities of long-term debt         1,120,998          909,057
   Revolving credit note                        1,105,949        1,603,368
   Deferred revenue                               388,967          385,742
   Current portion of obligations under
    capital leases                                203,401           57,881
   Accrued payroll, payroll taxes and benefits  1,510,571        1,619,672
   Accrued expenses and other liabilities       1,248,154        1,026,419
                                              ___________      ___________

       Total current liabilities                7,481,618        7,120,754
   Long-term debt                               1,006,783        1,021,546
   Obligations under capital leases                74,619           61,912
   Deferred tax liability                         325,000          325,000
                                              ___________      ___________
       Total liabilities                        8,888,020        8,529,212
                                              ___________      ___________
Stockholders' equity:
   Preferred Stock, 1,000,000 shares
    authorized, none issued or outstanding             --               --
   Class A common stock, $.01 par value,
    30,000,000 shares authorized,
    19,175,592 and 17,874,966 shares issued
    at December 31, 2006 and June 30, 2006,
    respectively                                  191,756          178,749
   Class B common stock, $.01 par value,
     2,000,000 shares authorized, 775,760
     issued and outstanding at December 31,
     2006 and June 30, 2006, respectively,
     each convertible into one share of
     Class A common Stock                           7,758            7,758
   Additional paid-in capital                  26,078,238       23,718,197
   Treasury stock, 199,098 shares of Class
     A common stock at December 31, 2006 and
     June 30, 2006, at cost                      (191,700)        (191,700)
Accumulated deficit                            (9,712,858)     (10,257,229)
                                              ___________      ___________
Total stockholders' equity                     16,373,194       13,455,775
                                              ___________      ___________
Total liabilities and stockholders' equity    $25,261,214      $21,984,987
                                              ===========      ===========


                                       9


                           PHC, INC. AND SUBSIDIARIES
                 CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
                                   (Unaudited)

                                    Three Months Ended       Six Months Ended
                                       December 31,             December 31,
                                     2006        2005         2006       2005
                                 ______________________    ___________________

                                                         
Revenues:
  Patient care, net          $7,946,670    $6,465,356   $15,823,102   $13,178,336
  Pharmaceutical studies        873,920     1,084,084     1,925,303     2,390,093
  Contract support services   1,131,770     1,153,073     2,266,161     2,078,910
                             __________    __________   ___________   ___________
    Total revenues            9,952,360     8,702,513    20,014,566    17,647,339
                             __________    __________   ___________   ___________
Operating expenses:
  Patient care expenses       4,243,531     3,292,393     8,199,183     6,554,304
  Patient care expenses,
   pharmaceutical               421,549       510,834       908,486     1,073,988
  Cost of contract support
   services                     687,174       587,067     1,525,729     1,184,862
  Provision for doubtful
   accounts                     347,458       475,768       799,983     1,132,655
  Administrative expenses     3,118,099     2,749,100     6,213,554     5,378,776
  Administrative expenses,
   pharmaceutical               529,555       538,291     1,208,663     1,172,290
                             __________    __________   ___________   ___________
    Total operating expenses  9,347,366     8,153,453    18,855,598    16,496,875
                             __________    __________   ___________   ___________
Income from operations          604,994       549,060     1,158,968     1,150,464
                             __________    __________   ___________   ___________
  Other income (expense):
      Interest income            33,808        15,397        66,657        38,261
      Other income (expense)     (3,135)       21,263        (4,078)       32,048
      Interest expense         (212,441)     (174,338)     (332,271)     (329,556)
                             __________    __________   ___________   ___________
    Total other expenses,
     net                       (181,768)     (137,678)     (269,692)     (259,247)
                             __________    __________   ___________   ___________

Income before provision for
 taxes                          423,226       411,382       889,276       891,217
Provision for income taxes      162,138        64,600       344,905       160,228
                             __________    __________   ___________   ___________

Net income                   $  261,088    $  346,782   $   544,371   $   730,989
                             ==========    ==========   ===========   ===========
Basic net income per
 common share                $     0.01    $     0.02   $      0.03   $      0.04
                             ==========    ==========   ===========   ===========

Basic weighted average
 number of shares
 outstanding                 18,758,151    18,159,188    18,636,146    18,125,265
                             ==========    ==========   ===========   ===========
Fully diluted net income
 per common share               $  0.01    $     0.02   $      0.03   $      0.04
                             ==========    ==========   ===========   ===========
Fully diluted weighted
 average number of shares
 outstanding                 19,409,232    19,301,486    19,280,727    19,302,592
                             ==========    ==========   ===========   ===========





                                       10